Sungai Buloh Hospital is a secondary and tertiary hospital located in Sungai Buloh, Petaling District, Selangor, Malaysia. The hospital covers an area of 130 acres. The hospital serves the districts of Gombak, Petaling and Kuala Selangor with a combined population of more than 2.80 million.

There are 620 beds in Hospital Sungai Buloh.

During the past decade, Hospital Sungai Buloh conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Sungai Buloh" #1 sponsor was "AO Clinical Investigation and Publishing Documentation" with 2 trials, followed by "Hospital Sultanah Bahiyah" with 2 trials sponsored, "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Sungai Buloh" #1 collaborator was "Hospital Enche Besar Hajjah Khalsom, Kluang, Johor" with 2 trials as a collaborator, "Hospital Melaka, Melaka" with 2 trials as a collaborator, "Hospital Queen Elizabeth, Malaysia" with 2 trials as a collaborator, "Hospital Raja Perempuan Zainab II, Kota Bahru, Kelantan" with 2 trials as a collaborator and "Hospital Raja Permaisuri Bainun" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Sungai Buloh" are "COVID-19" (4 trials), "Anosmia" (2 trials), "Dysgeusia" (2 trials), "SARS-CoV Infection" (2 trials) and "Arterial Thrombosis" (1 trials). Many other conditions were trialed in "Hospital Sungai Buloh" in a lesser frequency.

Most popular intervention types in "Hospital Sungai Buloh" are "Drug" (5 trials), "Other" (5 trials), "Procedure" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Patient-Reported Online Questionnaire on Olfactory & Taste Disturbances" (2 trials), "Placebo" (2 trials), "B/F/TAF" (1 trials), "Controlled vaccine" (1 trials) and "DTG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Sungai Buloh" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Sungai Buloh". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital Sungai Buloh, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Sungai Buloh, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".